ABcann Scores $30 Million Deal

Ontario-based ABcann Global Corporation (ABCCF) announced that it has entered into a binding interim agreement for a  proposed private placement of convertible senior unsecured debentures in the aggregate principal amount of $30,000,000. ABcann plans on using the money to make strategic acquisitions in the cannabis industry and for general working purposes.

“This financing will provide ABcann further capital to evaluate additional accretive opportunities as we strengthen our cash position to over $70 million,” commented Barry Fishman, CEO, and director of ABcann. “The stronger cash position will give us greater flexibility to execute our growth strategy, complete our current construction, and obtain larger-scale, cost-effective production capacity, which may include a greenhouse approach.”

The debentures will mature in 36 months and bear interest at 7% annually. It will be convertible ay $1.50 per share and be convertible, “at the option of the Company, into Shares if, at any time commencing four months plus one day following the closing date of the Financing, the daily volume weighted average trading price of the Shares on the TSX Venture Exchange  for any consecutive 10 day trading period is greater than $2.25 per Share.” Shares on the OTC Market were lately trading at $1.15, down from the 52-week high of $1.25.

ABcann recently strengthened the board by adding Mr. Richard Fitzgerald, who was Chairman of Diageo Canada Inc. until 2008, having previously served as Executive Director of Diageo’s Global Commercial Roadmap Initiative, and as President and CEO of Diageo for eight years. During his tenure, he was responsible for Diageo’s global category-leading brands, including Smirnoff®, Johnnie Walker®, Baileys®, and Guinness® in Canada.

The company also named Dr. Michael Bumby as the Chief Financial Officer of the Company, effective December 1, 2017. He brings extensive public company CFO, global pharmaceutical, and M&A experience to ABcann. Dr. Bumby succeeds Jenny Guan, who has been appointed Vice President and General Manager, Napanee Operations.

ABcann holds production and sales licenses from Health Canada. Its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centered on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products.

2 comments

  • Avatar
    Kerrie brown

    November 28, 2017 at 8:45 am

    I would like to thank you for your integrity in bringing forth unbiased information to the public. If I can help in these endeavors in any way please feel free to reach out. Truly, k.brown

    Reply

    • Debra Borchardt
      Debra Borchardt

      November 30, 2017 at 9:12 am

      Thanks Kerrie! We appreciate the support. Any help on social media would be support. We want FB page likes and Twitter followers.

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 7 hours

In case you missed it. Weed Talk News 10/16/2020 via @ProCannaMedia

@GreenMarketRpt – 3 days

Green Market Report’s Marijuana Money October 16, 2020

@GreenMarketRpt – 5 days

Green Market Report Wins Big During 2020 Awards Season

Back to Top

You have Successfully Subscribed!